INTERLEUKIN-1 α INCREASES THE EXPRESSION OF INTEGRIN α_Vβ_3 IN HUMAN PANCREATIC CANCER CELLS
-
- 栗本 昌明
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 沢井 博純
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 岡田 祐二
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 松尾 洋一
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 山本 稔
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 舟橋 整
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 竹山 廣光
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
-
- 真辺 忠夫
- Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences
この論文をさがす
抄録
Background and Aims: Pancreatic cancer is refractory to surgical treatment because of its high metastatic potential. We investigated the effect of IL-1 α on the expression of integrin α_Vβ_3 and tumor-associated angiogenesis in pancreatic cancer cell lines. Methods: We used three pancreatic cancer cell lines. The expression of integrin α_Vβ_3, mRNA and protein levels was examined by RT-PCR and flow cytometric analysis. The alteration of integrin α_Vβ_3 expression was measured using CELISA after treatment with rIL-1 α. A coculture system of HUVEC and fibroblasts was used to investigate tumor-associated angiogenesis. Results: Integrin cuand β_3 subunits were detected in all three cell lines both at mRNA and protein levels. The effect of the enhancement on integrin α_Vβ_3 expression induced by rIL-1 α was detected only in BxPC-3 cells, which possess a high potential to metastasize to the liver. Furthermore, a function blocking antibody to the α_Vβ_3 integrin inhibited tube formation associated with BxPC-3 cells. Conclusions: IL-1 α can increase the expression of the integrin α_Vβ_3 only in the pancreatic cancer cell line that exhibits a high potential to metastasize to the liver. Furthermore, the blockade of integrin α_Vβ_3 can inhibit tumor-associated angiogenesis, in vitro. These results suggested that IL-1 a is an important mediator of pancreatic cancer progression and that treatment with antibodies against integrin α_Vβ_3 may improve the prognosis of pancreatic cancer.
収録刊行物
-
- Nagoya medical journal
-
Nagoya medical journal 47 (3), 143-154, 2005-05-31
名古屋市立大学
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1571980076859408000
-
- NII論文ID
- 110004594339
-
- NII書誌ID
- AA00750902
-
- ISSN
- 00277649
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles